Stock SIGNAL GENETICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Signal Genetics Inc Nasdaq

Equities

US8266401046

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Signal Genetics Inc
Apr. 16 Foghorn Therapeutics Names Kristian Humer CFO MT
Mar. 21 B. Riley Lowers Viridian Therapeutics' PT to $25 From $29, Keeps Buy Rating; Adjusts Model to Reflect Recent Equity Offering, Quarterly Numbers MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. VRDN Stock
  4. Stock
  5. News Signal Genetics Inc
  6. Official Publications